THEO-24 300mg capsules

Country: Australia

Language: English

Source: Department of Health (Therapeutic Goods Administration)

Active ingredient:

theophylline, Quantity: 300 mg

Available from:

Proqualix Pty Ltd - in Administration

Pharmaceutical form:

Capsule

Composition:

Excipient Ingredients: colloidal anhydrous silica; ethylcellulose; Shellac; purified talc; Gelatin; titanium dioxide; brilliant blue FCF; allura red AC; maize starch; sucrose

Administration route:

Oral

Units in package:

Not Required

Prescription type:

Not scheduled. Not considered by committee

Therapeutic indications:

Indications for New Zealand and Singapore:THEO-24 is indicated for the relief and/or prevention of symptoms of asthma and for reversable bronchospasm associated with chronic bronchitis and emphysema.

Product summary:

Visual Identification: opaque red cap, clear colourless body; printed in black ink "searle" and "2852" on one part, "THEO-24" and "300mg" on the other; Container Type: Bottle; Container Life Time: 30 Months; Container Temperature: Store below 30 degrees Celsius

Authorization status:

Listed (Export Only)

Authorization date:

1991-11-27